A consortium of investors, including BPI France, Omnes Capital, Supernova Invest and Arbevel, has invested in cancer drug developer NH TherAguix.
Management team retains a minority stake in electrical engineering company Cesa-cap
Creamy Creation will retain its management team but Wagram will bring in a managing director
Company plans to consolidate its market position, and further expand internationally
New recruit will take on the role of investment and portfolio director at the growth capital firm